Purified anti-human CD279 (PD-1) Antibody, CD279, A17188B,BioLegend,621602

A17188B antibody can block the binding of NAT105 and EH12.2H7 antibodies to the target.

Host

Mouse

Reactivity

Human

Application

FC - Quality testedDirect ELISA - Verified

Platform ID

BAB300467644

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-human CD279 (PD-1) Antibody, CD279, A17188B
Cat. No.621602
HostMouse
RRIDAB_2820103 (BioLegend Cat. No. 621602)
IsotypeMouse IgG2b, κ
ReactivityHuman
ApplicationFC - Quality testedDirect ELISA - Verified
ClonalityMonoclonal
Clone NumberA17188B
Concentration0.5 mg/mL
TargetCD279
ImmunogenRecombinant human CD279 protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Programmed cell death protein 1 (PD-1), also known as CD279, is a 55 kD member of the immunoglobulin superfamily. CD279 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic region and plays a key role in peripheral tolerance and autoimmune disease. CD279 is expressed predominantly on activated T cells, B cells, and myeloid cells. PD-L1 (B7-H1, CD274) and PD-L2 (B7-DC, CD273) are ligands of CD279 (PD-1) and are members of the B7 gene family. Evidence suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells. Interaction of CD279 ligands results in inhibition of T cell proliferation and cytokine secretion.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.